Our strategic partners & advisors

The Hudson Institute of Medical Research at Monash University is a prominent cancer research body with a world-renowned reputation. They have 400 scientists to draw upon. We have been working with them to validate and confirm our cancer proteomics and biochemistry. Their work will have a pivotal role in our ongoing research. Their scientists have confirmed the activation of Immuno1's immune response.

Dr. Seb Marcuccio is an organic and pharmaceutical chemist with over 30 years in research and commercial development. He has secured multiple international patents. Currently, he is the Founder and Director of Advanced Molecular Technologies, specializing in medicinal chemistry and custom organic synthesis. He has made a profound contribution to Science by isolating and inventing the Synthetic Compound of the active ingredient that was used in the trials. He developed his Cancer Cell penetration methodology. He will be a leading force in finding other compatible and multiplying drug enhancers and/or dual drug approaches in our Skunk Works and Blue Sky program. 

With decades of combined experience in biotechnology, our team has the expertise and knowledge to develop solutions that are effective, safe, and sustainable.